An inhalable nanobody-based treatment prevented and treated SARS-CoV-2 infections in hamsters

(American Association for the Advancement of Science) An inhalable nanobody-based treatment may effectively prevent and treat SARS-CoV-2 infections when administered at ultra-low doses, according to a new study in Syrian hamsters. This novel therapy, Pittsburgh inhalable Nanobody 21 (PiN-21), could provide an affordable, needle-free alternative to monoclonal antibodies for
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news